Lifevantage Corporation LFVN Change in fair value of contingent consideration

Change in fair value of contingent consideration at other companies

Great Elm Group, Inc.GEG

$0—

TriSalus Life Sciences, Inc.TLSI

-$7.4M-1,003%

Limbach Holdings, Inc.LMB

$149K-65.1%

CareDxCDNA

$0-100%

Insight Molecular Diagnostics Inc. Common StockIMDX

-$5.92M-773%

Commvault SystemsCVLT

$0—

Other financials

Income statement

See full

Revenue$43.7M-25.2%

Gross profit$34.5M-27.0%

Operating income$1.7M-58.6%

Net income$1.4M-60.7%

EPS (diluted)$0.11-57.7%

Balance sheet

See full

Cash & equivalents$12.5M-44.4%

Total debt$10.2M-17.4%

Total equity$33.3M-2.0%

Total assets$62.1M-19.6%

Cash flow

See full

Operating cash flow$5.0M+124%

CapEx$1.0M+205%

Free cash flow$4.0M+110%

Valuation

See full

Market cap$78.72M-51.4%

Enterprise value$76.45M-50.2%

P/E13.7×-2.8×

P/S0.4×-0.3×

Profitability

See full

Gross margin78.1%-2.2pp

Operating margin3.4%-2.5pp

Net margin2.9%-1.2pp

FCF margin3.8%+1.1pp

Returns & leverage

See full

Return on equity17.1%-13.0pp

Debt / equity0.3×-0.1×

Current ratio2×+0.3×

Where this comes from

Reported directly by Lifevantage Corporation in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Lifevantage Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifevantage Corporation's change in fair value of contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifevantage Corporation's change in fair value of contingent consideration?: Lifevantage Corporation (LFVN) reported change in fair value of contingent consideration of -$100K in Q1 2026.